intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

C16 Biosciences, makers of Palmless™, ramps up in food fueled by fresh funding

C16 Biosciences, makers of Palmless™, ramps up in food fueled by fresh funding

January 24, 2024 Craig Etkin

January 24, 2024 09:00 AM Eastern Standard Time

NEW YORK–(BUSINESS WIRE)–C16 Biosciences, makers of Palmless™, the platform for sustainable palm oil alternatives, is ramping up its capabilities in the food category, fueled by a $3.5 million grant from the Bill & Melinda Gates Foundation as well as a $1 million investment from Elemental Excelerator.

“This is an excellent example of how innovation can reshape industries, in this case by replacing an ingredient that is a major contributor to deforestation and the displacement of indigenous communities.”

C16 Biosciences will use the designated funding from the Gates Foundation to expand the Palmless™ platform by working with non-agriculturally derived feedstocks to produce food-grade oils and fats. The global edible oils industry is projected to reach $870 billion by 2050, but the industry’s growth will be limited by insufficient arable land for oilseed crops to grow. C16 Biosciences has developed an innovative biomanufacturing process, leveraging yeast rather than plants, to produce oils and fats using fermentation. The company, supported by the new grant, will expand its fermentation platform to leverage next-generation feedstocks, which would enable a novel approach to food security, unlocking a circular economy model capable of producing food products and ingredients without dependence on arable land. With this grant, to be received over 3 years, C16 Biosciences will hire additional research and development staff.

“Creating better oils and fats for use in food has been a critical part of our company’s ambition and strategy from Day 1, but we’ve waited strategically for the right moment to enter the market,” says Co-Founder and CEO Shara Ticku. “Now that we’ve scaled our manufacturing to commercial-scale production and begun generating revenue in the personal care industry, we are ready and eager to expand our solution’s application set to produce high performance, scalable ingredients for food.”

C16 Biosciences has already gained significant momentum around its entry into the food category in 2023. On November 9th, C16 Biosciences was awarded the World Cell-base Innovation Award for “Best Cell-based Ingredient”. In October, the company joined Elemental Excelerator’s Cohort 12 and was awarded $1 million to advance efforts in food toward FDA GRAS status.

While C16 Biosciences is expanding its solution to the food category, the company remains focused on delivering innovative ingredients to its growing customer base in the beauty and personal care categories. In early 2023, the company launched Torula oil, a luxury bio-based oil for the beauty industry. Torula oil is the hero ingredient behind the company’s own product, Palmless™ Save the F#$%ing Rainforest Nourishing oil, and the REWILD Body Block, a collaboration with Pangaia and Haeckels sold at Selfridge’s UK and online. Both products sold out in under 24 hours, and the company is collaborating with dozens of beauty brands to launch products Made with Palmless™ in early 2024.

“With our support and catalytic investment, C16 Biosciences is taking pivotal steps to scale sustainable solutions, starting with palm oil alternatives for consumer products and food,” Elemental Excelerator Founder & CEO Dawn Lippert said. “This is an excellent example of how innovation can reshape industries, in this case by replacing an ingredient that is a major contributor to deforestation and the displacement of indigenous communities.”

About C16 Biosciences

C16 Biosciences is a New York-based biotech company producing biodesigned performance ingredients. We do this by leveraging our proprietary platform to produce novel ingredients without compromises for the world’s leading consumer goods manufacturers. The company recently launched the Palmless™ platform for sustainable ingredients as well as their first biodesigned ingredient, Torula oil, a luxury bioactive oil clinically proven to promote healthier skin and hair. Torula oil was the hero ingredient in two of 2023’s award-winning product launches, both of which sold out in <24 hours. The founders generated the idea for C16 Biosciences at the MIT Media Lab, and the company is backed by Breakthrough Energy Ventures, Y Combinator, and more.

Photography available at C16 Biosciences Press Kit

For more information, please contact: media@c16bio.com

About Elemental Excelerator

Elemental is a nonprofit investor in climate technologies with deep community impact. We bring more than a decade of experience across the climate sector, with an active and maturing portfolio of 150+ companies. Elemental fills two gaps fundamental to addressing climate change: funding projects for climate technologies in communities, and embedding equity and access into climate solutions. We invest in transformative technologies to create a systems change for a more resilient, equitable future.

Contacts

For more information, please contact: media@c16bio.com

(c)2024 Business Wire, Inc., All rights reserved.


Venture Capital
Business Wire, C16 Biosciences, New York, New York City, Palmless, Venture Capital

Post navigation

NEXT
Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways
PREVIOUS
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Infinite Reality, an innovation company powering the next generation of immersive media, AI, and ecommerce, today announced a landmark real estate partnership with renowned real estate investment, development and management firm Sterling Bay to co-develop a 60-acre site in Fort Lauderdale into a next-generation technology and entertainment campus. This ambitious redevelopment—expected to open in 2026—will serve as Infinite Reality’s new global headquarters and is the cornerstone of iR’s long-term real estate strategy, which begins with this flagship project in South Florida. The public-private project marks one of the largest creative economy investments in the area to date, aiming to generate more than 1,000 new jobs with an average salary of six figures and deliver long-term economic growth to the region. Located at 1400 NW 31st Avenue on the site of a remediated former Superfund property, the development features over 100,000 square feet of Class A office space for media, tech, and enterprise clients. Construction is expected to begin in early 2026, pending completion of permitting and design phases.

In a statement John Acunto, co-founder and CEO of Infinite Reality said, “This isn’t just a headquarters—it’s the heart of Infinite Reality’s future. As a proud South Florida resident, this project is deeply personal to me.” “It’s about transforming a community I love into a global hub for immersive technology and creativity. We’re building opportunity, fueling innovation, and laying the foundation for a lasting legacy. Partnering with a world-class development firm like Sterling Bay ensures that this vision is realized at the highest level—and that Fort Lauderdale becomes a defining force in the future of the digital economy.”

In addition to serving as a corporate campus, the site will include flexible spaces for retail, production, digital broadcasting, and entertainment ventures. The development also includes educational initiatives in partnership with local institutions to train and hire future talent in STEM, immersive tech, and creative production. Infinite Reality is an innovation company powering the next generation of digital media and ecommerce through spatial computing, artificial intelligence, and other immersive technologies. Infinite Reality’s suite of cutting-edge software, production, marketing services, and other capabilities empower brands and creators to craft inventive digital experiences that uplevel audience engagement, data ownership, monetization, and brand health metrics.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Load More... Subscribe

Categories

Recent Posts

  • Portal Access, Inc. Announces the closing of $7 Million Series A Financing Round to Support FDA Approval and Limited Market Launch of Next-Generation Chemotherapy Port June 10, 2025
  • CyrusOne to spend $400 Million to occupy 88,874 square feet of space in Whitney Texas. June 10, 2025
  • South Texas Health System to spend $1,936,193.00 to occupy 6,400 square feet of space in Mcallen Texas. June 10, 2025
  • Obvio Raises $22 Million to Deliver AI-Powered Traffic Safety and Prevent Traffic Deaths June 10, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.